3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
69
Carcinoma, Intraductal, Noninfiltrating
9
Breast Carcinoma In Situ
6
Breast Neoplasms, Male
5
Neoplasms
3
Neoplasm Metastasis
3
Urinary Bladder Neoplasms
2
Inflammatory Breast Neoplasms
2
Sleep Wake Disorders
1
Risk Reduction Behavior
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer
1
Mastodynia
1
Glioma
1
Fibrocystic Breast Disease
1
Fibroadenoma
1
Fatigue
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Disease Progression
1
Desmoid Tumors
1
Cystic Fibrosis
1
Cystadenocarcinoma, Serous
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Lobular
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Cancer Metastatic
1
Interventions
Magnetic Resonance Spectroscopy
2
Everolimus
2
Erlotinib Hydrochloride
2
ribociclib
1
palbociclib
1
olaparib
1
etoposide phosphate
1
erdafitinib
1
X-Rays
1
Sunitinib
1
Specimen Handling
1
Radiotherapy
1
Phantoms, Imaging
1
Nuclear Medicine Department, Hospital
1
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
1
Microarray Analysis
1
Lapatinib
1
Irinotecan
1
Immunologic Techniques
1
Immunohistochemistry
1
Immunoglobulin G
1
Ifosfamide
1
Fluorodeoxyglucose F18
1
Etoposide
1
Donepezil
1
Disulfides
1
Dasatinib
1
Cyproheptadine
1
Carboplatin
1
Blotting, Western
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Familial ependymoma
×
Tamoxifen
×
Clear all
No trials found.